source
- Genetix Biotherapeutics reports $327M YTD sales and projects $500M full-year revenue, marking profitabilityGenetix Biotherapeutics, the former bluebird bio, announced that it has become profitable, reporting $327 million in U.S. net sales year‑to‑date and forecasting total 2026 sales of about $500 milli…
- Vertex renews partnership with Genomics in up to $220 million, four-year extensionVertex Pharmaceuticals has extended its collaboration with sequencing specialist Genomics, signing a new agreement that can be worth up to $220 million. The extension adds four more years to the e…